| Literature DB >> 32294922 |
Yang Song1, Feng Ren1, Dong Sun2, Meizi Wang2, Julien S Baker3, Bíró István4, Yaodong Gu1.
Abstract
A coronavirus pandemic has recently become one of the greatest threats the world is facing. Older adults are under a high risk of infection because of weaker immune systems. Therefore, the purpose of this review is to summarize the recent scientific evidence that outlines the effects of exercise on influenza or pneumonia in older adults. An electronic literature search was conducted using the WEB OF SCIENCE, SCIENCEDIRECT and GOOGLE SCHOLAR databases using the following keywords, "Exercise," "Older adult," "Influenza," and "Pneumonia." Any randomized control trials, cross-sectional and observational studies that related to this topic were all included. Twenty studies met the eligibility criteria for this review. Thirteen randomized control trials investigated the effects of exercise on the immune responses to influenza or pneumonia vaccination: seven trials employed moderate aerobic exercise, three employed resistance exercise, and the remaining three used Asian martial arts or special home-based exercises. Five cross-sectional and two observational studies examined the associations between exercise/physical condition and influenza/pneumonia. Most of the current studies suggested that prolonged moderate aerobic exercise may help to reduce the risk of influenza-related infection and improve the immune responses to influenza or pneumonia vaccination in older adults. In addition, training in traditional Asian martial arts was also found to be beneficial. Future research should focus on the different effects of moderate and vigorous exercise on influenza-related diseases.Entities:
Keywords: exercise; influenza; older adults; pneumonia
Mesh:
Year: 2020 PMID: 32294922 PMCID: PMC7215850 DOI: 10.3390/ijerph17082655
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1The search flowchart.
The study characteristics of randomized controlled trials.
| Author and Year | Country | Disease | Sample Size (N) | Age (year) and Gender | Exercise |
|---|---|---|---|---|---|
| Bohn-Goldaum et al. (2019) [ | Australia | Influenza | N = 46 | Age: EG = 74.4 ± 6.5; CG = 72.3 ± 6.7 | EG: Resistance exercise |
| Dangour et al. (2011) [ | Britain | Pneumonia | N = 1500 | Age: EG = 66.1 ± 0.9; NS + EG = 66.2 ± 1.0; CG = 66.1 ± 1.0 | EG: Resistance exercise + recreational activities |
| Edwards et al. (2015) [ | Australia | Influenza | N = 46 | Age: 73 ± 7 | EG: Resistance exercise |
| Hayney et al. (2014) [ | USA | Influenza | N = 98 | Age: EG = 59.0 ± 6.6; CG = 58.8 ± 6.8 | EG: Sustained exercise |
| Kohut et al. (2004) [ | USA | Influenza | N = 27 | Age: EG = 73.07 ± 5.6; CG = 70.25 ± 5.6 | EG: Aerobic exercise |
| Kohut et al. (2005) [ | USA | Influenza | N = 27 | Age: EG = 70.25 ± 5.57; CG = 73.07 ± 5.59 | EG: Aerobic exercise |
| Long et al. (2012) [ | Britain | Influenza + Pneumonia | N = 62 | Age: EG = 57.94 ± 4.40; CG = 58.55 ± 4.38 | EG: Aerobic exercise |
| Matsumoto et al. (2015) [ | Japan | Pneumonia | N = 208 | Age: EG = 74.5 ± 5.6; CG = 74.9 ± 6.6 | EG: Home-based exercise with expiratory muscle training |
| Ranadive et al. (2014) [ | USA | Influenza | N = 55 | Age: EG = 66 ± 0.93; CG = 67 ± 0.77 | EG: Aerobic exercise |
| Takatori et al. (2016) [ | Japan | Pneumonia | N = 266 | Age: EG = 74.6 ± 5.1; CG = 75.9 ± 6.0 | EG: Specifically home-based exercise programme |
| Vieira et al. (2008) [ | USA | Influenza | N = 145 | Age: 60–83 | EG: Cardiovascular exercise |
| Woods et al. (2009) [ | USA | Influenza | N = 144 | Age: EG = 69.6 ± 4.9; CG = 70.1 ± 5.7 | EG: Cardiovascular exercise |
| Yang et al. (2007) [ | USA | Influenza | N = 50 | Age: EG = 79.5 ± 1.9; CG = 74.1 ± 2.0 | EG: Qigong and Taiji form practice |
Note: exercise group, EG; control group, CG; nutritional supplement, NS; male, M; female, F.
The study characteristics of cross-sectional and observational studies.
| Author and Year | Country | Disease | Sample Size (N) | Age (year) and Gender |
|---|---|---|---|---|
| de Araújo et al. (2015) [ | Brazil | Influenza | N = 61 | Age: Intense exercise = 74.8 ± 1.5; Moderate exercise = 70.4 ± 0.7; Never exercise = 72.9 ± 1.5 |
| Keylock et al. (2007) [ | Korea | Influenza | N = 26 | Age: Physically active, high-fit = 64.8 ± 1.2; Sedentary, low-fit = 67.9 ± 1.2 |
| Kohut et al. (2002) [ | USA | Influenza | N = 56 | Age: Active = 71.9 ± 5.2; Moderately active = 70.7 ± 6.3; Sedentary = 71.5 ± 7.1 |
| Moehling et al. (2017) [ | USA | Influenza | N = 114 | Age: Group1: Non-frail = 56.1–61.0, Frail = 54.4–61.8; Group2: Non-frail = 66.6–73.6, Frail = 68.1–74.0 |
| Schuler et al. (2003) [ | USA | Influenza | N = 30 | Age: 81 ± 5; Gender: M = 10; F = 20 |
| Wong et al. (2008) [ | Hong Kong, China | Influenza | N = 24,656 | Age: 30–64 (21%), 65-(79%) |
| Yao et al. (2011) [ | USA | Influenza | N = 71 | Age: Non-frail = 82.0 ± 5.4; Pre-frail = 85.4 ± 4.1; Frail = 86.0 ± 3.1 |
The main findings of studies.
| Author & Year | Study Design and Intervention | Primary Results |
|---|---|---|
|
| ||
| Bohn-Goldaum et al. (2019) [ | RCT | (1) No significant differences between groups over 6 months for antibody response to influenza immunization. |
| Dangour et al. (2011) [ | RCT | (1) No significant differences between groups for the incidence rate of pneumonia at 24-month time point. |
| Edwards et al. (2015) [ | RCT | (1) No significant differences between groups at baseline, 1 or 6-month time points for antibody response to influenza immunization. |
| Hayney et al. (2014) [ | RCT | (1) No significant differences between groups over 8 months to influenza immunization. |
| Kohut et al. (2004) [ | RCT | (1) EG have significantly greater antibody response to influenza immunization. |
| Kohut et al. (2005) [ | RCT | (1) EG have significantly greater antibody response to influenza immunization. |
| Long et al. (2012) [ | RCT | (1) No significant differences between groups for antibody response to influenza and pneumonia immunization at four-week time point. |
| Matsumoto et al. (2015) [ | RCT | (1) EG have significantly greater effects for prevention of aspiration pneumonia. |
| Ranadive et al. (2014) [ | RCT | (1) No significant differences between groups for antibody response to influenza immunization, except women in the EG. |
| Takatori et al. (2016) [ | RCT | (1) EG have significantly greater effects for prevention of aspiration pneumonia. |
| Vieira et al. (2008) [ | RCT | (1) EG with pre-vaccination experiences have significantly greater antibody response to influenza immunization at 24-week time point. |
| Woods et al. (2009) [ | RCT | (1) EG have significantly greater seroprotection rate to influenza immunization at 24-week time point. |
| Yang et al. (2007) [ | RCT | (1) EG have significantly greater antibody response to influenza immunization at 3, 6, and 20-week time points. |
|
| ||
| de Araújo et al. (2015) [ | X-Sec | (1) Both moderate and intense exercise lifestyle contribute to greater antibody response to influenza immunization. |
| Keylock et al. (2007) [ | X-Sec | (1) High-fit elderly have significantly greater antibody response to influenza immunization. |
| Kohut et al. (2002) [ | X-Sec | (1) Regular, vigorous aerobic exercise is associated with greater antibody response to influenza immunization. |
| Moehling et al. (2017) [ | Obs | (1) Antibody responses to influenza vaccine is greater in non-frail persons > 65, while an opposite results occurred in persons between 50–65 years old. |
| Schuler et al. (2003) [ | X-Sec | (1) Positive correlation between physical activity and antibody response to influenza immunization. |
| Wong et al. (2008) [ | X-Sec | (1) Low to moderate exercise (1 time/month to 3 times/week) contributes to lowest influenza-associated mortality. |
| Yao et al. (2011) [ | Obs | (1) Non-frail older adults have greater antibody response to influenza vaccine and lower rates of influenza infection. |
Note: Randomized Controlled Trial, RCT; Cross-sectional, X-Sec; Observational, Obs; Heart Rate Reserve, HHR; Heart Rate, HR; Exercise Group, EG; Control Group, CG; Nutritional Supplement, NS.